National Institute of Health / FDA GMP / Network Scientific Committee / World Health Organization / Brazilian National Health Surveillance Agency / Thailand Food and Drug Administration / United States Food and Drug Administration / Global Fund / HHS / United States Agency for International Development / State Food and Drug Administration / European Medicines Agency / Review Committee / European Free Trade Association / FDA / European Union / Network Committee / Green Light Committee / /
Position
investigator / Program Director / Site Leader / Principal Investigator / President / The CRS Leader / CRS leader / The DAIDS Program Director / The Network Protocol Chair / Program Officer / Medical Officer / DAIDS Program Officer / onsite senior research scientist / DAIDS Program Director / Governor / Clinical Research Site Leader The Clinical Research Site Leader / DAIDS Program Director / DAIDS Medical Officer / and DAIDS Program Officer / Principal Investigator and the Program Director / POLICY NOT ACTIVE Principal Investigator The Principal Investigator / Protocol Chair / Network Protocol Chair / DAIDS Program Director The DAIDS Program Director / DAIDS Program Director / along with any necessary supporting documentation / /
DAIDS Bethesda, MD USA ARCHIVED POLICY Use of Study Products Not Marketed in the United States Approval Date: 24 JUN 2011 Effective Date: 24 JUN 2011